Related Experiment Video
Updated: Jun 15, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes
Marc Le Vee1, Elodie Jouan, Amélie Moreau
1EA 4427 Signalisation et Réponse aux Agents Infectieux et Chimiques, Institut de Recherches en Santé Environnement Travail, Université de Rennes 1, Rennes, France.
Abstract:
Interferon (IFN)-γ is known to downregulate expression of drug detoxifying proteins such as cytochromes P-450 (CYPs) in human hepatocytes. The present study was designed to determine whether IFN-γ may also impair expression of influx and efflux drug transporters, which constitute important determinants of the liver detoxification pathway. Exposure of primary human hepatocytes to 10 ng/mL IFN-γ was found to downregulate mRNA levels of sinusoidal influx transporters such as sodium-taurocholate cotransporting polypeptide, organic anion transporting polypeptide (OATP) 2B1, OATP1B1, and OATP1B3. IFN-γ concomitantly reduced mRNA expression of drug efflux pumps such as multidrug resistance gene 1, multidrug resistance protein (MRP) 2, MRP3, breast cancer resistance protein and bile salt export pump. Such IFN-γ-mediated repression of major hepatic drug transporters may contribute to impaired liver clearance of drugs administrated to patients suffering from inflammation or viral infections associated with increased secretion of IFN-γ.
Insights
Interferon-gamma (IFN-γ) reduces key liver drug transporters, including influx and efflux proteins. This impairment may affect how the body processes medications during inflammation or viral infections.
Area of Science:
- Hepatology
- Pharmacology
- Immunology
Background:
- Interferon-gamma (IFN-γ) is known to decrease drug-metabolizing enzymes like cytochromes P-450 (CYPs) in liver cells.
- Drug transporters are crucial for liver detoxification, influencing drug absorption and elimination.
Purpose of the Study:
- To investigate the impact of IFN-γ on the expression of hepatic drug influx and efflux transporters.
- To determine if IFN-γ affects the liver's drug transport system.
Main Methods:
- Primary human hepatocytes were exposed to 10 ng/mL of IFN-γ.
- Messenger RNA (mRNA) levels of various drug transporters were quantified.
Main Results:
- IFN-γ significantly downregulated mRNA levels of sinusoidal influx transporters, including sodium-taurocholate cotransporting polypeptide and organic anion transporting polypeptides (OATP1B1, OATP1B3, OATP2B1).
- IFN-γ also reduced the expression of efflux transporters, such as multidrug resistance gene 1, multidrug resistance proteins (MRP2, MRP3), breast cancer resistance protein, and bile salt export pump.
Conclusions:
- IFN-γ suppresses the expression of major hepatic drug influx and efflux transporters.
- This suppression may lead to reduced drug clearance in patients with inflammatory or viral conditions characterized by elevated IFN-γ levels.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Regulated mRNA Transport
Regulated mRNA Transport
Regulation of Expression at Multiple Steps
Cell Specific Gene Expression
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...

